Greenleaf Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.36M Sell
36,612
-2,514
-6% -$220K 0.03% 150
2026
Q1
$3.33M Buy
39,126
+1,097
+3% +$97.8K 0.03% 136
2025
Q4
$3.01M Buy
38,029
+3,901
+11% +$306K 0.03% 142
2025
Q3
$2.73M Buy
34,128
+4,459
+15% +$380K 0.02% 152
2025
Q2
$2.7M Sell
29,669
-876
-3% -$80K 0.02% 155
2025
Q1
$2.86M Sell
30,545
-2,422
-7% -$217K 0.03% 149
2024
Q4
$3M Sell
32,967
-598
-2% -$57.1K 0.03% 141
2024
Q3
$3.48M Buy
33,565
+33
+0.1% +$3.36K 0.03% 130
2024
Q2
$3.25M Buy
33,532
+1,106
+3% +$102K 0.03% 128
2024
Q1
$2.92M Buy
32,426
+72
+0.2% +$6.1K 0.03% 133
2023
Q4
$2.58M Buy
32,354
+2,301
+8% +$173K 0.03% 147
2023
Q3
$2.14M Buy
30,053
+314
+1% +$23.5K 0.02% 152
2023
Q2
$2.29M Buy
29,739
+1,152
+4% +$89.2K 0.02% 146
2023
Q1
$2.15M Buy
28,587
+2,342
+9% +$174K 0.02% 155
2022
Q4
$2.07M Sell
26,245
-5,562
-17% -$417K 0.03% 156
2022
Q3
$2.23M Sell
31,807
-978
-3% -$76.7K 0.03% 136
2022
Q2
$2.63M Sell
32,785
-1,129
-3% -$88.3K 0.04% 109
2022
Q1
$2.57M Sell
33,914
-120,586
-78% -$9.55M 0.03% 114
2021
Q4
$13.2M Buy
154,500
+1,510
+1% +$118K 0.15% 39
2021
Q3
$11.6M Buy
152,990
+9,863
+7% +$783K 0.14% 38
2021
Q2
$11.6M Buy
143,127
+9,698
+7% +$793K 0.14% 39
2021
Q1
$10.5M Buy
133,429
+2,713
+2% +$213K 0.14% 40
2020
Q4
$11.2M Buy
130,716
+14,368
+12% +$1.19M 0.15% 39
2020
Q3
$8.98M Buy
116,348
+3,294
+3% +$251K 0.14% 39
2020
Q2
$8.28M Buy
113,054
+12,738
+13% +$905K 0.15% 40
2020
Q1
$6.66M Buy
100,316
+7,569
+8% +$534K 0.13% 39
2019
Q4
$6.38M Buy
92,747
+770
+0.8% +$52.5K 0.1% 49
2019
Q3
$6.76M Buy
91,977
+2,790
+3% +$202K 0.11% 45
2019
Q2
$6.39M Buy
89,187
+2,468
+3% +$175K 0.1% 48
2019
Q1
$5.94M Sell
86,719
-4,040
-4% -$261K 0.1% 49
2018
Q4
$5.4M Sell
90,759
-12,174
-12% -$762K 0.11% 47
2018
Q3
$6.89M Buy
102,933
+1,823
+2% +$121K 0.12% 44
2018
Q2
$6.55M Buy
101,110
+5,719
+6% +$374K 0.12% 45
2018
Q1
$6.84M Buy
95,391
+675
+0.7% +$48.6K 0.14% 44
2017
Q4
$7.15M Sell
94,716
-934
-1% -$68.2K 0.15% 42
2017
Q3
$6.97M Sell
95,650
-6,998
-7% -$504K 0.15% 40
2017
Q2
$7.61M Sell
102,648
-6,932
-6% -$515K 0.17% 31
2017
Q1
$8.02M Sell
109,580
-11,163
-9% -$781K 0.19% 31
2016
Q4
$7.9M Sell
120,743
-15,294
-11% -$1.05M 0.21% 33
2016
Q3
$10.1M Buy
136,037
+2,038
+2% +$151K 0.27% 25
2016
Q2
$9.81M Sell
133,999
-14,068
-10% -$1M 0.25% 28
2016
Q1
$10.5M Buy
148,067
+136,942
+1,231% +$9.11M 0.28% 30
2015
Q4
$741K Hold
11,125
0.02% 94
2015
Q3
$706K Buy
11,125
+53
+0.5% +$3.46K 0.02% 89
2015
Q2
$724K Hold
11,072
0.02% 91
2015
Q1
$768K Hold
11,072
0.02% 93
2014
Q4
$766K Hold
11,072
0.02% 89
2014
Q3
$722K Hold
11,072
0.02% 89
2014
Q2
$755K Sell
11,072
-50
-0.4% -$3.35K 0.02% 93
2014
Q1
$721K Buy
11,122
+50
+0.5% +$3.15K 0.02% 93
2013
Q4
$722K Sell
11,072
-200
-2% -$12.8K 0.02% 98
2013
Q3
$668K Sell
11,272
-232
-2% -$13.7K 0.03% 96
2013
Q2
$659K Buy
+11,504
New +$683K 0.03% 97

Other funds holding CL

Greenleaf Trust's CL Position: Q2 2026 in Review

Greenleaf Trust reduced its Colgate-Palmolive (CL) stake by 6.4% in Q2 2026, selling an estimated $220K and leaving 36,612 shares worth $3.36M. The position accounts for 0.03% of the portfolio, ranked #150.

Greenleaf Trust first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.2M in Q4 2021. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Greenleaf Trust held 36,612 shares of Colgate-Palmolive worth $3.36M as of Q2 2026.
  • Greenleaf Trust sold 2,514 Colgate-Palmolive shares in Q2 2026, an estimated $220K.
  • Colgate-Palmolive made up 0.03% of Greenleaf Trust's portfolio in Q2 2026, its #150 holding.
  • Greenleaf Trust first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Greenleaf Trust's Colgate-Palmolive position peaked at $13.2M in Q4 2021.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.